Advertisement Vetter, Sentry Biopharma Form Filling, Labelling, Packaging Partnership - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vetter, Sentry Biopharma Form Filling, Labelling, Packaging Partnership

Vetter, a provider of aseptic pre-filled drug-delivery systems and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement for filling, labelling and packaging of biopharmaceuticals.

Vetter will fill early-stage, high-value biopharmaceuticals at its Chicago facility; Sentry will label, package and ship the clinical supplies from its site in Indianapolis, Indiana. The collaboration will help streamline the path of study drugs from filling lab to clinic while safeguarding product integrity.

Peter Soelkner, managing director of Vetter, said: “Our partnership with Sentry affirms our mutual commitment to helping clients get high-quality products to market quickly and efficiently. It also affirms Vetter’s commitment to the North American market.

“The Chicago facility, which focuses on preclinical to Phase II projects, is Vetter’s first outside of Germany and is an expansion of Vetter Development Service. It will be operational at the beginning of Q4 2010.”

Jennifer Marcum, CEO of Sentry, said: “We’re proud to partner with Vetter. In addition, we’re both privately held companies with central US locations allowing rapid response to industry needs and accessibility to clients across North America.”